Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF) (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 37.09% year-over-year to $1.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.3 million (down 26.62% YoY) and the FY2025 annual result came in at $6.4 million, down 10.48% from the prior year.
• Depreciation & Amortization (CF) retreated to $1.1 million in Q2 2026, from $1.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.2 million in Q3 2024 to a low of $422000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 275.07% — and 2026, when it plunged 37.09%.
• Tracing BCYC's Depreciation & Amortization (CF) over 5 years: stood at $1.4 million in 2022, then climbed by 19.34% to $1.7 million in 2023, then increased by 3.02% to $1.7 million in 2024, then declined by 21.6% to $1.3 million in 2025, then slipped by 20.13% to $1.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 million (Q2 2026), $1.1 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.